Galilee Medical Center

Nahariya, Northern District 2210001

0 studies enrolling now · 5 studies all time

What they study most

Acute Ischemic Stroke, Crohn's Disease, Heart Failure With Preserved Ejection Fraction (HFpEF), Nonalcoholic Steatohepatitis, Obesity, Type 2 Diabetes Mellitus

Studies at this site

• A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke — Completed
• A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes — Completed
• A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Running, not enrolling
• A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial — Completed
• A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH) — Completed